Xponential Fitness, Inc.
NYSE:XPOFLeisure
+$0.33 today
- Market cap
- $202.36M
- Beta
- 1.12
- P/E (TTM)
- -7.8
- EPS (TTM)
- -$0.89
Volume 0.43M
Average 0.53M
XPOF Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Xponential Fitness, Inc.NYSE: XPOF
Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026
Cost of revenue declines year over year
Q1 FY2026 cost of revenue of $9.14M fell 64.0% year over year, behind the -44.7% change in trailing-twelve-month cost of revenue. Sequentially, it fell 52.7% from the prior quarter. Over 3 fiscal years it compounded at -2.2% a year.
Context
- Cost of revenue amounted to 24.4% of revenue in FY2025, up 5.8 pp from a year earlier.
- Cost of revenue increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -64.0% toward the trailing-twelve-month pace of -44.7%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 76.78M USD
- Year-over-year change
- +29.1%
- 4-year CAGR
- +9.0%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 76.78M | +29.1% |
| FY2024 | 2024-12-31 | 59.48M | -39.7% |
| FY2023 | 2023-12-31 | 98.62M | +20.0% |
| FY2022 | 2022-12-31 | 82.19M | +51.3% |
| FY2021 | 2021-12-31 | 54.31M | — |
Cost of Revenue vs competitors
How XPOF compares with its peers on the latest reported figures
- Peers report in different currencies, so cost of revenue is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -44.7% is the lowest of 7, against a peer median of -7.6%.
- Cost of revenue amounts to 20.1% of revenue for XPOF, versus a peer median of 61.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $958.13M USD | -7.8% | -9.3% | 61.9% | |
| LTM Mar 2026 | $555.16M USD | -7.4% | -14.4% | 60.4% | |
| LTM Feb 2026 | $382.7M USD | — | -13.0% | 67.8% | |
| LTM Apr 2026 | $289.85M USD | -4.2% | -9.2% | 69.8% | |
| LTM Mar 2026 | $175.77M USD | -6.6% | -9.5% | 73.1% | |
| LTM Mar 2026 | $152.96M USD | -16.0% | -12.4% | 38.7% | |
| LTM Jun 2025 | €134.74M EUR | -15.1% | -18.3% | 46.3% | |
| LTM Mar 2026 | $59.97M USD | -44.7% | -2.2% | 20.1% | |
| LTM Mar 2026 | $135K USD | — | +31.0% | — | |
| Peer median (excluding XPOF) | — | -7.6% | -10.9% | 61.9% | |
Competitors are the stored peer set for XPOF. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 155.08M | 243.2M | 317.94M | 320.35M | 314.88M |
| Cost of Revenue | 54.31M | 82.19M | 98.62M | 59.48M | 76.78M |
| Gross Profit | 100.77M | 161.01M | 219.32M | 260.87M | 238.1M |
| Gross Margin | 65.0% | 66.2% | 69.0% | 81.4% | 75.6% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 87.97M | 115.98M | 148.53M | 176.85M | 158.56M |
| Operating Expenses | 131.59M | 147.69M | 184.42M | 314.48M | 158.56M |
| Depreciation & Amortization | 10.17M | 15.32M | 16.88M | 17.71M | 12.03M |
| EBITDA | 12.8M | 45.03M | 70.79M | (35.08M) | 8.87M |
| EBITDA Margin | 8.3% | 18.5% | 22.3% | -10.9% | 2.8% |
| Operating Income | (30.82M) | 13.32M | 34.91M | (53.61M) | 79.55M |
| Operating Margin | -19.9% | 5.5% | 11.0% | -16.7% | 25.3% |
| Interest Income | 1.16M | 1.81M | 1.61M | 1.82M | 3.21M |
| Interest Expense | 24.71M | 13.02M | 38.73M | 46.25M | 49.19M |
| Other Income / Expenses | (19.84M) | (11.74M) | (40.32M) | (45.42M) | (131.9M) |
| Income Before Tax | (50.66M) | 1.59M | (5.41M) | (99.04M) | (52.35M) |
| Pre-Tax Margin | -32.7% | 0.7% | -1.7% | -30.9% | -16.6% |
| Income Tax Expense | 783K | 488K | 1.03M | (342K) | 1.32M |
| Net Income | (18.83M) | 1.22M | (4M) | (64.95M) | (33.79M) |
| Net Margin | -12.1% | 0.5% | -1.3% | -20.3% | -10.7% |
| EPS (Basic) | (2.67) | (0.87) | 1.08 | (2.27) | (1.47) |
| EPS (Diluted) | (2.67) | (0.87) | (0.52) | (2.27) | (1.47) |
| Weighted Avg Shares | 23.9M | 25.3M | 31.74M | 32M | 34.8M |
| Weighted Avg Shares (Diluted) | 23.9M | 25.3M | 39.71M | 32M | 34.8M |
Xponential Fitness, Inc.
NYSE:XPOF
Intrinsic Alpha fair value
Locked
Current Price
$4.76
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.